Next Article in Journal
Gigantea: Uncovering New Functions in Flower Development
Next Article in Special Issue
Membrane-Anchored Hairless Protein Restrains Notch Signaling Activity
Previous Article in Journal
Pathogenic Variant Filtering for Mitochondrial Genome Haplotype Reporting
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Limited Availability of General Co-Repressors Uncovered in an Overexpression Context during Wing Venation in Drosophila melanogaster

Department of General Genetics 190g, University of Hohenheim, Garbenstr. 30, 70599 Stuttgart, Germany
*
Author to whom correspondence should be addressed.
Submission received: 29 July 2020 / Revised: 17 September 2020 / Accepted: 25 September 2020 / Published: 28 September 2020
(This article belongs to the Special Issue Regulating Gene Activity By Sequestering Transcriptional Regulators)

Abstract

:
Cell fate is determined by the coordinated activity of different pathways, including the conserved Notch pathway. Activation of Notch results in the transcription of Notch targets that are otherwise silenced by repressor complexes. In Drosophila, the repressor complex comprises the transcription factor Suppressor of Hairless (Su(H)) bound to the Notch antagonist Hairless (H) and the general co-repressors Groucho (Gro) and C-terminal binding protein (CtBP). The latter two are shared by different repressors from numerous pathways, raising the possibility that they are rate-limiting. We noted that the overexpression during wing development of H mutants HdNT and HLD compromised in Su(H)-binding induced ectopic veins. On the basis of the role of H as Notch antagonist, overexpression of Su(H)-binding defective H isoforms should be without consequence, implying different mechanisms but repression of Notch signaling activity. Perhaps excess H protein curbs general co-repressor availability. Supporting this model, nearly normal wings developed upon overexpression of H mutant isoforms that bound neither Su(H) nor co-repressor Gro and CtBP. Excessive H protein appeared to sequester general co-repressors, resulting in specific vein defects, indicating their limited availability during wing vein development. In conclusion, interpretation of overexpression phenotypes requires careful consideration of possible dominant negative effects from interception of limiting factors.

Graphical Abstract

1. Introduction

During development, cell fate is adjusted by inter-cellular communication mediated by several signaling pathways including the Notch pathway. Notch is highly conserved from fly to human, having been linked to a number of congenital diseases as well as oncogenesis in humans (reviewed in [1,2]). Hence, there is great interest in the understanding of the molecular mechanisms underlying the regulation of Notch signaling activity, which can be well addressed in the fruit fly Drosophila melanogaster. Activation of the Notch pathway by ligand–receptor interaction causes the proteolytic release of the Notch intracellular domain (NICD) that acts as a transcriptional co-activator in the nucleus—together with several additional co-factors, an activator complex is assembled on the Notch target genes driving their transcription. Central to the activator complex is CSL (composite of human C-promoter binding factor 1 (CBF1), fly Suppressor of Hairless (Su(H)), and nematode Lin-12 and Glp-1 phenotype (Lag-1)), a DNA-binding transcription factor that guides the activator complex to Notch target gene promoters (reviewed in [1,3,4,5]). In Drosophila, CSL is named Suppressor of Hairless (Su(H)). CSL transcription factors act as a molecular switch since in the absence of receptor activation they assemble repressor complexes on Notch target genes to silence their transcription (reviewed in [5,6,7]). To this end, Drosophila Su(H) binds the Notch antagonist Hairless (H), which recruits the general co-repressors Groucho (Gro) and C-terminal binding protein (CtBP), eventually inhibiting Notch target gene expression [8,9,10,11].
Intriguingly, the general co-repressors Gro and CtBP are shared by a number of different repressors that act in various pathways that govern the development of different tissues of Drosophila (reviewed in [12,13,14]). Both Gro and CtBP proteins are highly conserved and ubiquitously expressed throughout development to serve their role as general co-repressors [12,13,15,16]. However, because of their joint use by a large number of transcription factors [17,18], it is conceivable that they may be rate-limiting in certain developmental processes or contexts. Within the Notch signaling pathway, these co-repressors serve opposing functions. Firstly, as outlined above, both are assembled in the repressor complex together with Hairless and Su(H) to silence Notch target genes [8,9] (reviewed in [7,10,11]). Secondly, primary Notch target genes belonging to the Enhancer of split complex (E(spl)-C), encode basic helix-loop-helix proteins that together with Gro act as transcriptional repressors of proneural genes [17,19,20,21,22,23,24] (reviewed in [12,25]). Accordingly, lack of Gro might likewise hamper the repression and the activity of the Notch effectors.
Notch activity is severely downregulated by the overexpression of H because of the repression of Notch target genes. Performed in a tissue-specific manner, H overexpression affects tissue growth, as well as the development of the peripheral nervous system, the eye, and the wing. The resultant phenotypes are all typical for a loss of Notch activity. For example, Notch activity is required for distinguishing dorsal from ventral compartment in the developing wing, and eventually for the formation of the wing margin [26,27]. Compromising Notch activity in this process causes wings to develop characteristic notches, giving the name for the mutant in Drosophila [9,26,27,28,29,30]. Moreover, Notch is involved in wing vein formation, restricting vein competent cells to the vein proper [31,32] (reviewed in [33,34,35]). Accordingly, a gain of Notch activity results in gaps, whereas a loss of Notch results in thickened, knotted veins [28,29,31,32,36]. Previously, we noted that the overexpression of a HC2 mutant lacking the Su(H) binding domain induced ectopic veinlets when overexpressed during larval development [36] (Figure 1a,d,e). Formally, this phenotype is unrelated to repression of Notch activity since repressor complex formation was abolished. A systematic genetic analysis, however, revealed a strong interaction with Notch on the one hand, and with the Epidermal growth factor receptor (EGFR) signaling pathway on the other hand [36]. EGFR signaling is tightly involved in vein development of Drosophila [31,34,35,36,37]. In general, ectopic veins form when the EGFR pathway is hyperactive, and not are confined to the presumptive veins [30,31]. Interestingly, Groucho has been placed at the crossroads of the Notch and EGFR signaling pathways [38]. Hence, we wondered whether the overexpression of H may sequester the general co-repressors Gro and CtBP, thereby causing the observed phenotypes.
Here, we provide evidence that this is indeed the case in the context of wing vein development. We analyzed mutations in H that specifically affect Su(H)-binding (HdNT, HLD), i.e., repressor complex assembly. Accordingly, the overexpression of these constructs does not induce typical Notch loss of function phenotypes expected from excess of wild type H gene activity [9,39,40,41]. However, ectopic veinlets formed independent of Su(H) binding activity. We directly tested the hypothesis that venation defects may result from a sequestration of the co-repressors by excessive H protein in this developmental context. To this end, we introduced, in addition, mutations in H-destroying co-repressor binding as well. As predicted from the model, overexpression of these H mutants defective for binding Su(H), Gro, and CtBP resulted in wings with nearly wild type phenotypes. However, subtle vein defects suggest that H protein may recruit additional co-repressors that are likewise curbed by H overexpression. Overall, our data demonstrate that the co-repressors Gro and CtBP are rate-limiting in the context of Drosophila wing development.

2. Materials and Methods

2.1. Generation of H Mutant Constructs and UAS-Fly Lines Deficient for Su(H) and Co-Repressor Binding

Generation of UAS (upstream activating sequence) constructs containing the wild type H cDNA or the HC2, HdNT, HLD, and H*CG mutant versions has been described earlier [9,29,36,40]. Whereas the total Su(H) binding domain is deleted in HC2 and essential parts thereof in HdNT, the L235D amino acid replacement in HLD compromises Su(H) binding [40,41,42]. The H*GC mutant carries several amino acid replacements that prevent the binding of both co-repressors, Gro and CtBP (Figure 1a) [9]. These mutations were introduced into already existing UAS-attB HdNT and HLD constructs, respectively, by replacement of the C-terminal EcoR I DNA fragment with the respective mutant DNA derived from H*GC in order to generate the triple mutant UAS constructs HdNT*GC and HLD*GC. Constructs were sequence verified before integration at 68E by PhiC31 mediated recombination, as were earlier the starting constructs HdNT*GC and HLD*GC [40,43]. PCR and diagnostic restriction digests were used for genotyping of the fly strains. Moreover, expression of H protein was confirmed (see Figure S1). The UAS-HdNT*GC and UAS-HLD*GC lines were recombined with UAS-Su(H) at 96E by genetic recombination, as outlined before for HdNT and HLD [40].

2.2. Yeast Two-Hybrid Assays

The procedure for the Brent yeast two-hybrid assay has been earlier outlined in detail [44,45]. The pEG202 vector encodes the LexA DNA binding domain to be fused to the bait construct. The pJG4-5 vector encodes the B42 transactivation domain and the VP16-vector of VP16, each to be fused to the prey construct [44,45]. Binding of the two fusion proteins reconstitutes the trans-activator in the transfected yeast cell, resulting in transcriptional activation of the lacZ reporter detectable by blue coloration of the yeast on respective X-Gal plates. For the prey constructs, we used pJG-Su(H), VP16-Gro, and VP16-CtBP [9]. The full-length H pEG-bait constructs pEG-H, pEG-H*G, and pEG-H*C were described earlier [9,29]; the full length pEG-HdNT and pEG-HLD constructs were generated in this work. They are based on the respective mutant UAS-H* constructs: the mutant DNA was amplified with Q5 high fidelity DNA polymerase (New England Biolabs) using the primer pair pEG_Hup 5’ caa tga atc cat ggg ccc tgc t 3’ and pEG_Hlo 5’ agt gcg aaa atg ttc tta agt cga ctg g 3’, digested at the Nco I and Sal I sites contained within the primers (bold), and ligated into Nco I/Xho I-opened pEG 202 vector. All constructs were sequence verified. Empty vectors served as control.

2.3. Phenotypic Analyses

The Gal4/UAS system was employed for tissue-specific overexpression [46]. We used the following UAS-H* lines, all placed at chromosomal position 68E on 3L: UAS-H, UAS-HLD [9], UAS-HdNT [39], UAS-HdNT*GC, and UAS-HLD*GC (this work), as well as the respective stocks recombined with UAS-Su(H) at 96E [40]. UAS-HC2 [36], UAS-H*GC [47], and UAS-GFP served as control. As driver lines, we used omb-Gal4 expressed within the central part of the wing field [48] and QE-Gal4 [49], where Gal4 is expressed in the pattern of the vestigial quadrant enhancer, i.e., in the presumptive wing blade only, sparing dorso-ventral and antero-posterior boundaries [50]. Crosses were kept on standard fly food at 25 °C, 20 °C, or 18 °C, as indicated, taking advantage of the temperature sensitivity of the Gal4/UAS system. Variance of phenotypes was rather low (see Figures S2 and S3). Wings of female flies only were dehydrated in ethanol and mounted in Euparal (Roth GmbH, Karlsruhe, Germany). Pictures were taken with either a Pixera 120es or Pro300D camera (Pixera Cooperation, CA, USA) mounted on a Zeiss Axiophot (Carl Zeiss AG, Jena, Germany) using Pixera Viewfinder Pro2.5 software. Pictures were assembled using Photo Paint and Corel Draw software.

3. Results

3.1. H Constructs Deficient for Su(H) and Co-Repressor Binding

The H protein is characterized by three interactive motifs: the Su(H)-binding domain (SBD) contacts Su(H) with its N-terminal (NT)-box, whereas the Groucho-binding domain (GBD) and the CtBP-binding domain (CBD) contact the co-repressors Gro and CtBP, respectively (Figure 1a) [8,9,39,40,51,52]. Recently, the crystal structure of the H-Su(H) repressor complex uncovered an unusual hydrophobic interaction between the two proteins—H NT deeply reaches into the C-terminal domain of Su(H), where primarily leucine residues are in contact with each other (Figure 1b) [53]. To address the contribution of either component to H function, mutations have been introduced into the respective binding sites (Figure 1a,b) [9,40,42]. The H*G and H*C point mutations indicated in Figure 1a affect the contact sites for Gro and CtBP, respectively [12]. We have shown earlier that these mutations impede co-repressor recruitment by H, and accordingly the strength of H-mediated repression [9,47,54]. Indeed, in the yeast two-hybrid assay, H*G does not bind to Gro, and H*C does not bind to CtBP, whereas the binding to Su(H) was unaffected (Figure 1c) [9].
Accordingly, mutations within the H-Su(H) interface affected the interaction between the two proteins in a yeast two-hybrid assay (Figure 1a–c). For example, HdNT lacks the NT-box (amino acids G232 to S270) including most relevant amino acids required for the binding of Su(H) [39,40,53]. In HLD, the amino acid leucin235 within the Su(H) interface was replaced by the bulky and charged aspartate residue, expected to interfere with Su(H) binding (Figure 1a,b) [40,42,53]. Correspondingly, HLD did not bind to Su(H) in the yeast two-hybrid assay (Figure 1c). Interaction with either co-repressor Gro or CtBP, however, was not influenced by any of the mutations impairing the Su(H) interface (Figure 1c).

3.2. Overexpression of Su(H) Binding-Deficient H Proteins Resulted in Ectopic Veinlet Formation

Earlier, we showed that the overexpression of a HC2 variant induced a specific wing phenotype characterized by a plexus of ectopic veinlets [36], which we also observed when overexpressing HC2 in the presumptive wing field proper (Figure 1d,e). To this end, we employed the Gal4/UAS system for tissue-specific overexpression of HC2 using the QE-Gal4 line [46,49]. In this line, the vestigial quadrant enhancer controls expression within the entire wing field, sparing antero-posterior and dorso-ventral boundaries [50]. The HC2 mutant protein is unable to bind to Su(H), i.e., to assemble repressor complexes [9]. Accordingly, downregulation of Notch activity can hardly explain the HC2 overexpression phenotypes. Rather, genetic interactions point to an interference with EGFR signaling activity [36], perhaps by interfering with co-repressor availability. The substantial size of the HC2 deletion (Figure 1a) moreover raised the possibility that HC2 may have defects in addition to Su(H) binding relevant to the observed phenotypes. We hence wondered whether H* variants affecting Su(H) binding in particular might elicit similar phenotypes. On the basis of the structure analysis, respective mutations have been generated previously, allowing us to directly address this question (Figure 1a–c) [40,42,53].
First, we aimed to address the biological activity of the Su(H)-binding deficient H* mutants UAS-HdNT and UAS-HLD with regard to vein development. We and others have shown before that the overexpression of H induces strong developmental defects that result from a repression of Notch activity [9,26,29,39,40,41,47,49,52,56,57]. Phenotypic strength can hence serve as readout of residual H activity in an overexpression context. To avoid position effects and allow for a direct comparison of the respective constructs, we placed UAS-HdNT and UAS-HLD at the identical chromosomal position on the left arm of the third chromosome at position 68E by PhiC31-mediated integration, as outlined previously [40,43]. Expression of the constructs was confirmed (see Figure S1).
The principal H activity is the assembly of repressor complexes at Notch target gene promoters. Accordingly, the overexpression of H* transgenes deficient for the binding to Su(H) has little developmental consequences. As shown earlier, the selection of mechano-sensory organs, growth as well as differentiation of the eye were largely normal in an overexpression context of either HdNT or HLD mutants [40,41]. Likewise, the formation of the wing margin, which requires a specific activation of Notch and its targets wingless and vestigial along the dorso-ventral boundary in the wing imaginal disc [26,50], was not affected by the overexpression of either HdNT or HLD mutant [40]. Whereas the overexpression of wild type H in the central wing anlagen with omb-Gal4 induced strong wing incisions (Figure 2a,b) [9,40], the wing margin developed normally, inducing either HdNT or HLD in excess (Figure 2a–d). Instead, a subtle wing vein phenotype was observed—ectopic veinlets appeared in the distal part of the wing in the intervein regions reminiscent of what has been seen with HC2 (Figure 1e and Figure 2c,d).

3.3. Ectopic Vein Formation Was Independent of Su(H)

To further analyze the venation defects, we switched to the QE-Gal4 line for expression within the presumptive wing field [49]. Overexpression of H with QE-Gal4 resulted in thickened veins and smaller wings compared to control (Figure 3a,b). In addition, a partial detachment of the dorsal and ventral wing epithelia was frequently observed, causing wing blisters (Figure 3b). In contrast, overexpression of any of the two Su(H)-binding defective H* transgenes HdNT or HLD induced knotting of the longitudinal vein L2 and ectopic veinlets at the posterior cross-vein and along the longitudinal L2 and L5 veins (Figure 3c,d). This phenotype is remarkably similar to HC2 overexpressed in the quadrant pattern (Figure 1d,e), in support of the idea that overexpression of H* isoforms defective for Su(H)-binding elicit these effects.
If there were residual binding between the mutant H* proteins and Su(H), the observed phenotypes might still be a consequence of Notch signaling repression. Overexpression of H strongly downregulates Notch activity, causing typical Notch loss of function phenotypes such as thickened veins [29,32]. Notably the knotted L2 veins seen in the QE-Gal4-induced wings are reminiscent of the sole H overexpression (Figure 3b), in support of residual H activity in the mutants. In this case, we would expect a more severe phenotype to arise from a combined overexpression together with Su(H). As observed by several groups before, the co-overexpression of H and Su(H) results in an extreme repression of Notch activity, and hence strong phenotypes arise, including larval or pupal lethality [9,40,52,53,57]. Indeed, co-overexpression of H with Su(H) in the central wing anlagen using the omb-Gal4 driver line caused pupal lethality even at lower temperature (Figure 2b’). In contrast, combinations with HdNT or HLD were viable, and the resultant wings resembled those of the sole Su(H) overexpression (Figure 2a’,c’,d’), in support of a failure of repressor complex formation with any of the mutant H* isoforms together with Su(H).
Overexpression of Su(H) with QE-Gal4 caused shortening of longitudinal veins at their distal ends, easily explained by a gain of Notch activity (Figure 3a’) [32,33,34,35,36]. In combination with H, Su(H) overexpression caused much smaller wings with extremely broadened L2 and L5 veins, as if the entire provein field had turned into vein character (Figure 3b’), a typical sign of strong Notch inhibition [32]. Moreover, accessory mechano-sensory bristles developed along these veins (enlarged in Figure 3b’), indicating gain of proneural gene activity. In contrast, the combination of Su(H) with either HdNT or HLD did not affect wing size, only causing a slight knotting of distal L2 and L5, and, occasionally, a gap in distal L4 or L5, i.e., a mixed phenotype (Figure 3c’,d’). Together these data show that the mutant proteins HdNT and HLD have lost Su(H)-binding activity, however, they still elicit the formation of ectopic veinlets. However, we should note that direct in vivo evidence of non-binding is lacking.

3.4. Overexpression Phenotypes Were Dependent on Co-Repressor Recruitment

We wondered whether excessively overexpressed H* protein might intercept the activity of its co-repressors Gro and CtBP. Both co-repressors are recruited by a multitude of other repressors [12,13,17,18], and if sequestered, may affect vein formation. In this case, H proteins lacking both co-repressor binding as well as Su(H) binding should not induce wing venation phenotypes. To this end, the respective triple mutant UAS lines were established (HdNT*GC and HLD*GC) (Figure 1a), as well as the constructs overexpressed in the central part of the wing anlagen using omb-Gal4 (Figure 4) and in the presumptive wing field using QE-Gal4 (Figure 5).
We have shown before that H*GC strongly affects H repressor activity during wing and eye development [9,47,54], in agreement with the pivotal role of the co-repressors in repressor complex functions. Accordingly, the overexpression of UAS-H*GC with omb-Gal4 affected wing margin formation to a much lesser degree compared to UAS-H (Figure 4b,b’). Moreover, overexpression of H*GC with QE-Gal4 allowed normal wing venation (Figure 5b,b’). Strikingly, nearly normal wing vein development was observed upon the overexpression of any H* mutant affecting both Su(H) and co-repressor binding—neither extensive ectopic vein formation nor vein knotting was observed (Figure 4c–d’ and Figure 5c–d’). Wing size, however, albeit significantly improved compared to Su(H)-binding defective H* mutants, was still markedly reduced relative to control wings when overexpressing the triple mutants HdNT*GC and HLD*GC in the omb pattern (Figure S2). Moreover, we still noted subtle venation defects when inducing either HdNT*GC or HLD*GC with the QE-Gal4 at higher temperatures in about half of the specimens (Figure 5c’,d’ and Figure S3). These phenotypes may point to additional co-repressors likewise involved in wing vein development. When contacting H at sites other than Gro and CtBP, such co-repressors are expected to bind to the mutant H* isoforms and might be likewise depleted by H* overexpression. Whether these include known chromatin remodeling factors such as Asf1 or still others remains to be determined [58,59].

4. Discussion

Formation of wing vein primordia and differentiation of veins are controlled primarily by three signaling pathways in Drosophila, namely, EGFR, Notch, and Decapentaplegic (Dpp, i.e., Transforming growth factor ß-like) [33,34,35,60]. No veins develop in the absence of either EGFR or Dpp, or in excess of Notch activity [33]. During larval development, EGFR activity defines pro-vein and inter-vein territories, and the increase in EGFR activity induces a plexus of ectopic veins [30,33]. Notch activity, however, refines pro-vein territories to the veins proper. Accordingly, downregulation of Notch results in thickened and knotted veins, whereas upregulation inhibits vein formation altogether [34,35]. Activity of Dpp is required in the pupal stage for the initiation and maintenance of the vein differentiation program. In addition, several downstream transcription factors eventually specify the final veins [34,35,60,61,62].
We provide evidence that the overexpression of H* mutant protein incapable of Su(H)-binding causes the formation of ectopic veinlets by sequestration of co-repressors. Notably, Gro has been shown before to be pivotal to the regulation of EGFR-signaling activity in the wing, and has been placed at the crossroads of the Notch and EGFR signaling during embryogenesis as well as wing development of Drosophila [36,38,63]. In fact, Gro is a target of Mitogen-activated protein kinase (MAPK) activity downstream of EGFR activation, and phosphorylation by MAPK impedes Gro repressor capacity [38]. In addition, EGFR signaling activity may directly intercept with Notch signaling at the level of H and Su(H) as well, since either protein is a phospho-target of MAPK in Drosophila [49,64], as is CSL in the mouse [65].
We propose a model, whereby excessive H* protein defective in Su(H)-binding—and hence unable to form repressor complexes to silence Notch target genes—sequesters general co-repressors Gro and CtBP (Figure 6). Ectopic veinlets form because of limited availability of the co-repressors rather than because of a specific H activity. Both co-repressors, Gro and CtBP, are shared by numerous transcription factors acting in different pathways, including Notch, EGFR, and Dpp pathways (reviewed in [12,13,25]). Presumably, the widespread relief of repression underlies the observed phenotypes, rather than the interception of a single, specific transcription repressor. This hypothesis is in line with the observation that a vast majority of transcription factors (around 80%) involved in wing development recruit the co-repressors Gro and/or CtBP [66]. These data were deduced from a large-scale in vivo screen, where transcription factors were either overexpressed during wing development or downregulated by RNA interference, and wing phenotypes recorded [66]. Comparing the author’s results with the list of physical interaction partners curated in flybase, we found that 85% of Gro partners and 75% of CtBP partners induced wing defects. Accordingly, limited availability of Gro and/or CtBP may affect the activity of many different transcription factors at once. We consider Capicua (Cic), Brinker (Brk), and E(spl)/Hairy the most likely candidates, acting in EGFR, Dpp, and Notch signaling pathways, respectively, and each involved in wing vein development [30,36,62,66,67] (Figure 6).

4.1. Influences on EGFR Signaling Activity

It is well established that the upregulation of EGFR signaling activity results in ectopic vein formation [30,31,33,68]. Either gain of EGFR activity or the loss of one of its antagonists may induce ectopic veinlets [67,68,69,70,71]. For example, capicua (cic) encodes a transcriptional repressor downstream of EGFR and of Dpp signaling activity. Cic is required for the specification of intervein fate by acting as a repressor—together with its co-repressor Gro—of vein-specific genes, for example vvl, aos, and dpp [67,72]. In the absence of Gro, Cic loses its silencing activity. Accordingly, cic mutants display numerous ectopic veins specifically along the L2 and the distal L4 and L5 veins [67], i.e., exactly in the regions where we observed ectopic veinlets (Figure 1e). Moreover, cell clones mutant for Gro display extra veins, similarly to cic clones [63]. Cic repressor function may be affected in cases of restricted Gro availability, and ectopic veins would result (Figure 6).

4.2. Influences on Dpp Signaling Activity

During pupal development, dpp signaling activity is required in cells committed for vein fate. Expression of dpp is prefigured by EGFR and Notch activities, defining the presumptive vein territories. In fact, dpp activity is sufficient for inducing vein differentiation within the wing field [33,62]. As outlined above, a Cic–Gro repressor complex inhibits expression of dpp, and hence Dpp signaling activity [67]. Moreover, the activity of dpp is confined by Brinker (Brk) that is specifically expressed in the interveins [62]. Brk acts as a transcriptional repressor and recruits both co-repressors Gro and CtBP [73,74]. Brk-induced repression of Dpp during wing development can elicit venation phenotypes that are very similar to H* overexpression [75,76]. Assuming limited availability of either or both co-repressors, Brk’s activity might be impeded, lifting Dpp repression, and hence allowing for the formation of ectopic veinlets (Figure 6).
Similarly, the repressor Scribbler (Sbb; also named Master of thickveins, Mtv) and its co-repressor Gro influence Dpp activity through the regulation of the Dpp receptor Thickveins. Accordingly, cells lacking sbb execute vein fate [77], which might also be expected in the absence of Gro [63]. However, sbb was not amongst the transcription factors recovered in a systematic in vivo screen for genes regulating wing development [66]. Another transcription repressor downstream of Dpp is Knirps (Kni). Kni is specific to the formation of the L2 vein, recruiting both co-repressors Gro and CtBP [78,79]. Absence of co-repressors is expected to result in gaps rather than ectopic veins.

4.3. Does H Recruit Additional Co-Repressors?

Our data provide evidence that H may recruit additional co-repressors apart from Gro and CtBP, since the overexpression of the triple mutants HdNT*GC and HLD*GC still affected wing size (Figure 4) and induced some remnant veins (Figure 5). Residual binding to Su(H) appears an extremely unlikely explanation, as HdNT*GC deletes most of the Su(H)-binding domain (Figure 1a), and co-expression of Su(H) did not enhance the observed phenotypes (Figure 2c’,d’). Formally, H* may compete with the primary Notch signaling executers, the HES protein family (Hairy-Enhancer of split) for binding to the Gro co-repressor. In the Notch signaling pathway, Gro serves as co-repressor in opposing ways: firstly, together with H in Notch target gene repression, and secondly, as co-repressor of the bHLH proteins encoded by the primary Notch targets of the Enhancer of Split E(spl)/HES family (reviewed in [10,25,80]). When Notch signals are executed, they are involved in eventually refining vein width [32,33,34,35]. In case of limited Gro availability, their activity might be reduced, and ectopic veins may be a consequence (Figure 6).
Additional co-repressors of H may involve chromatin modifiers such as anti-silencing factor 1 (Asf1), and indirectly Sin3A and Sirtuin 1 (Sirt1) [58,59,81]. Asf1 is a nucleosome remodeler involved in epigenetic regulation of Notch signal transduction, binding to H in this context [58,59]. As part of multi-protein complexes, Asf1 together with histone deacetylases Sin3A and HDAC1 is involved in the silencing of Notch target genes [58,59]. Recently, however, Sin3A was shown to promote rather than repress Notch signaling activity during wing margin formation [82]. Su(H) directly contacts Sin3A as well as the Sirt1, whereas Asf1 binds to Gro, adding additional complexity to possible competition amongst co-repressors [58,59,81]. During wing development, Sirt1 has a positive effect on Notch activation in Drosophila and participates in the deacetylation of Su(H) [81]. Sirt1 mutant wings develop ectopic veins similar to H* overexpression mutants [81]. Accordingly, a limitation of Sirt1 availability by H* overexpression is in agreement with the observed residual ectopic veinlets. In addition to a direct effect on Su(H) activity by deacetylation, the role of Sirt1 during wing vein development may be indirect and involve the epigenetic gene regulator Kismet (Kis). Kis encodes an ATP-dependent chromodomain transcription factor that interacts with Sirt1 [81,83]. Kis was originally identified as a genetic modifier of EGFR activity, and loss of kis leads to the development of ectopic veins due to elevated levels of EGFR signaling activity [68,84]. Moreover, Sirt1 forms a repressor complex with the lysine-specific demethylase LSD1/Su(var)3-3, regulating Notch and Dpp signaling pathways, respectively, in the developing wing [85,86,87]. Along with Sirt1, CoREST, CtBP, HDAC1/2, and others, LSD1 assembles in a repressor complex mediating histone modifications [88]. Intervein cells mutant for either lsd1 or its cofactor CoRest adopt vein cell fate, indicating that the complex functions to repress vein formation [86,87]. Limited availability of CtBP by intercepting H* protein may likewise impede Sirt1–LSD repressor complex function, followed by ectopic vein formation.

5. Conclusions

The data presented in this work support our working hypothesis, proposing that the general co-repressors Gro and CtBP may be rate-limiting in specific developmental contexts exemplified for wing venation. Numerous transcriptional regulators recruit either one or both co-repressors Gro and CtBP, the activity of each being possibly impaired provided the limited availability of the co-repressors. Accordingly, the overexpression of any one of these regulators—for instance, Hairless—may induce dominant negative phenotypes by lowering co-repressor availability. These phenotypes, hence, do not necessarily reflect the function of the protein under investigation but are rather an impaired activity of other regulators inflicted by reduced co-repressor levels. We substantiated our working hypothesis for H in the context of wing vein development—H overexpression induced ectopic veinlet formation, which is normally masked by the manifold phenotypes—including wing phenotypes—arising from Notch inhibition, but uncovered by H* variants defective for Su(H) binding. As these H* variants cannot repress Notch signaling activity, the venation phenotype most likely reflects interference with other signaling pathways that result from depletion of co-repressors Gro and CtBP.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/2073-4425/11/10/1141/s1, Figure S1: Expression of H* mutant proteins, Figure S2: Phenotypic variance of wings from females derived from a cross with omb-Gal4, Figure S3: Phenotypic variance of wings from females derived from a cross with QE-Gal4.

Author Contributions

Conceptualization, A.C.N., A.P., and D.M.; methodology, A.C.N. and A.P.; validation, A.C.N., A.P., and D.M.; investigation, A.C.N., A.P., D.M., J.S., and M.K.; resources, A.C.N., A.P., D.M., and M.K.; data curation, A.C.N., A.P., and D.M.; writing—original draft preparation, A.P.; writing—review and editing, A.C.N., A.P., and D.M.; visualization, A.C.N. and A.P.; supervision, A.C.N. and D.M.; project administration, A.P.; funding acquisition, A.C.N. and D.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by grants from the Deutsche Forschungsgemeinschaft DFG (http://www.dfg.de) to A.C.N. (NA 427/5-1) and D.M. (MA 1328/11-1) and by the University of Hohenheim. Some Drosophila fly stocks were obtained from the Bloomington Drosophila Stock Center (BDSC), funded by the National Science Foundation (NIH P40OD018537) (https://www.nih.gov). Some information was obtained from Flybase, funded by the National Human Genome Research Institute (https://www.genome.gov) and the British Medical Research Council (https://mrc.ukri.org).

Acknowledgments

We greatly acknowledge P. Kurth and K. Gruber for their help in the generation of constructs and the initial characterization of some fly lines. We are indebted to T. Mönch, A. Schulz, R. Seiler, and M. Zimmermann for technical help. We thank the reviewers for their insightful comments and help towards considerably improving the manuscript.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Bray, S.J. Notch signalling: A simple pathway becomes complex. Nat. Rev. Mol. Biol. 2006, 7, 678–689. [Google Scholar] [CrossRef] [PubMed]
  2. Louvi, A.; Artavanis-Tsakonas, S. Notch and disease: A growing field. Sem. Cell Dev. Biol. 2012, 23, 473–480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Kovall, R.A.; Blacklow, S.C. Mechanistic insights into Notch receptor signaling from structural and biochemical studies. Curr. Top. Dev. Biol. 2010, 92, 31–71. [Google Scholar] [CrossRef] [PubMed]
  4. Wang, H.; Zang, C.; Liu, X.S.; Aster, J.C. The role of Notch receptors in transcriptional regulation. J. Cell Physiol. 2015, 230, 982–988. [Google Scholar] [CrossRef] [PubMed]
  5. Bray, S.J. Notch signalling in context. Nat. Rev. Mol. Biol. 2016, 17, 722–735. [Google Scholar] [CrossRef]
  6. Borggrefe, T.; Oswald, F. The Notch signaling pathway: Transcriptional regulation at Notch target genes. Cell. Mol. Life Sci. 2009, 66, 1631–1646. [Google Scholar] [CrossRef] [Green Version]
  7. Maier, D. The evolution of transcriptional repressors in the Notch signaling pathway: A computational analysis. Hereditas 2019, 156, 5. [Google Scholar] [CrossRef]
  8. Barolo, S.; Stone, T.; Bang, A.G.; Posakony, J.W. Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless. Genes Dev. 2002, 16, 1964–1976. [Google Scholar] [CrossRef] [Green Version]
  9. Nagel, A.C.; Krejci, A.; Tenin, G.; Bravo-Patiño, A.; Bray, S.; Maier, D.; Preiss, A. Hairless-mediated repression of Notch target genes requires the combined activity of Groucho and CtBP co-repressors. Mol. Cell. Biol. 2005, 25, 10433–10441. [Google Scholar] [CrossRef] [Green Version]
  10. Maier, D. Hairless, the ignored antagonist of the Notch signalling pathway. Hereditas 2006, 143, 212–221. [Google Scholar] [CrossRef]
  11. Borggrefe, T.; Oswald, F. Setting the stage for Notch: The Drosophila Su(H)-Hairless repressor complex. PLoS Biol. 2016, 14, e1002524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Buscarlet, M.; Stifani, S. The ‘Marx’ of Groucho on development and disease. Trends Cell Biol. 2007, 17, 353–361. [Google Scholar] [CrossRef] [PubMed]
  13. Chinnadurai, G. CtBP family proteins: More than transcriptional corepressors. BioEssays 2003, 25, 9–12. [Google Scholar] [CrossRef] [PubMed]
  14. Mannervik, M. Control of Drosophila embryo patterning by transcriptional co-regulators. Exp. Cell Res. 2014, 321, 47–57. [Google Scholar] [CrossRef] [PubMed]
  15. Hartley, D.A.; Preiss, A.; Artavanis-Tsakonas, S. A deduced gene product from the Drosophila neurogenic locus, Enhancer of split, shows homology to mammalian G-protein beta subunit. Cell 1988, 55, 785–795. [Google Scholar] [CrossRef]
  16. Poortinga, G.; Watanabe, M.; Parkhurst, S.M. Drosophila CtBP: A Hairy-interacting protein required for embryonic segmentation and hairy-mediated transcriptional repression. EMBO J. 1998, 17, 2067–2078. [Google Scholar] [CrossRef] [Green Version]
  17. Paroush, Z.; Finley, R.L., Jr.; Kidd, T.; Wainwright, S.M.; Ingham, P.W.; Brent, R.; Ish-Horowicz, D. Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins. Cell 1994, 79, 805–815. [Google Scholar] [CrossRef]
  18. Jiménez, G.; Paroush, Z.; Ish-Horowicz, D. Groucho acts as a corepressor for a subset of negative regulators, including Hairy and Engrailed. Genes Dev. 1997, 11, 3072–3082. [Google Scholar] [CrossRef] [Green Version]
  19. Jennings, B.; Preiss, A.; Delidakis, C.; Bray, S. The Notch signalling pathway is required for Enhancer of split bHLH protein expression during neurogenesis in the Drosophila embryo. Development 1994, 120, 3537–3548. [Google Scholar]
  20. Lecourtois, M.; Schweisguth, F. The neurogenic Suppressor of Hairless DNA-binding protein mediates the transcriptional activation of the Enhancer of split complex genes triggered by Notch signaling. Genes Dev. 1995, 9, 2598–2608. [Google Scholar] [CrossRef] [Green Version]
  21. Bailey, A.M.; Posakony, J.W. Suppressor of Hairless directly activates transcription of Enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 1995, 9, 2609–2622. [Google Scholar] [CrossRef] [PubMed]
  22. Eastman, D.S.; Slee, R.; Skoufos, E.; Bangalore, L.; Bray, S.; Delidakis, C. Synergy between Suppressor of Hairless and Notch in regulation of Enhancer of split m gamma and m delta expression. Mol. Cell. Biol. 1997, 17, 5620–5628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Castro, B.; Barolo, S.; Bailey, A.M.; Posakony, J.W. Lateral inhibition in proneural clusters: Cis-regulatory logic and default repression by Suppressor of Hairless. Development 2005, 132, 3333–3344. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Krejčí, A.; Bernard, F.; Housden, B.E.; Collins, S.; Bray, S.J. Direct response to Notch activation: Signaling crosstalk and incoherent logic. Sci. Signal. 2009, 2, ra1. [Google Scholar] [CrossRef] [PubMed]
  25. Jennings, B.H.; Ish-Horowicz, D. The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol. 2008, 9, 205. [Google Scholar] [CrossRef]
  26. Diaz-Benjumea, F.J.; Cohen, S.M. Serrate signals through Notch to establish a Wingless-dependent organizer at the dorsal/ventral compartment boundary of the Drosophila wing. Development 1995, 121, 4215–4225. [Google Scholar]
  27. de Celis, J.F.; Garcia-Bellido, A.; Bray, S.J. Activation and function of Notch at the dorsal-ventral boundary of the wing imaginal disc. Development 1996, 122, 359–369. [Google Scholar]
  28. Rebay, I.; Fehon, R.G.; Artavanis-Tsakonas, S. Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell 1993, 74, 319–329. [Google Scholar] [CrossRef]
  29. Maier, D.; Marquart, J.; Thompson-Fontaine, A.; Beck, I.; Wurmbach, E.; Preiss, A. In vivo structure-function analysis of Drosophila Hairless. Mech. Dev. 1997, 67, 97–106. [Google Scholar] [CrossRef]
  30. Sotillos, S.; de Celis, J.F. Interactions between the Notch, EGFR, and decapentaplegic signaling pathways regulate vein differentiation during Drosophila pupal wing development. Dev. Dyn. 2005, 232, 738–752. [Google Scholar] [CrossRef]
  31. Sturtevant, M.A.; Bier, E. Analysis of the genetic hierarchy guiding wing vein development in Drosophila. Development 1995, 121, 785–801. [Google Scholar] [PubMed]
  32. de Celis, J.F.; Bray, S.; Garcia-Bellido, A. Notch signalling regulates veinlet expression and establishes boundaries between veins and interveins in the Drosophila wing. Development 1997, 124, 1919–1928. [Google Scholar] [PubMed]
  33. de Celis, J.F. Positioning and differentiation of veins in the Drosophila wing. Int. J. Dev. Biol. 1998, 42, 335–344. [Google Scholar] [PubMed]
  34. de Celis, J.F. Pattern formation in the Drosophila wing: The development of the veins. Bioessays 2003, 25, 443–451. [Google Scholar] [CrossRef]
  35. Blair, S.S. Wing vein pattering in Drosophila and the analysis of intercellular signaling. Annu. Rev. Cell Dev. Biol. 2007, 23, 293–319. [Google Scholar] [CrossRef]
  36. Johannes, B.; Preiss, A. Wing vein formation in Drosophila melanogaster: Hairless is involved in the cross-talk between Notch and EGF signaling pathways. Mech. Dev. 2002, 115, 3–14. [Google Scholar] [CrossRef]
  37. Martín-Blanco, E.; Roch, F.; Noll, E.; Baonza, A.; Duffy, J.B.; Perrimon, N. A temporal switch in DER signaling controls the specification and differentiation of veins and interveins in the Drosophila wing. Development 1999, 126, 5739–5747. [Google Scholar]
  38. Hasson, P.; Paroush, Z. Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE. Br. J. Cancer. 2006, 94, 771–775. [Google Scholar] [CrossRef] [Green Version]
  39. Maier, D.; Chen, A.X.; Preiss, A.; Ketelhut, M. The tiny Hairless protein from Apis mellifera: A potent antagonist of Notch signaling in Drosophila melanogaster. BMC Evol. Biol. 2008, 8, 175. [Google Scholar] [CrossRef] [Green Version]
  40. Maier, D.; Kurth, P.; Schulz, A.; Russell, A.; Yuan, Z.; Gruber, K.; Kovall, R.A.; Preiss, A. Structural and functional analysis of the repressor complex in the Notch signaling pathway of Drosophila melanogaster. Mol. Cell. Biol. 2011, 22, 3242–3252. [Google Scholar] [CrossRef]
  41. Kurth, P.; Preiss, A.; Kovall, R.A.; Maier, D. Molecular analysis of the Notch repressor-complex in Drosophila: Characterization of potential Hairless binding sites on Suppressor of Hairless. PLoS ONE 2011, 6, e27986. [Google Scholar] [CrossRef] [Green Version]
  42. Praxenthaler, H.; Smylla, T.K.; Nagel, A.C.; Preiss, A.; Maier, D. Generation of new Hairless alleles by genomic engineering at the Hairless locus in Drosophila melanogaster. PLoS ONE 2015, 10, e0140007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Bischof, J.; Maeda, R.K.; Hediger, M.; Karch, F.; Basler, K. An optimized transgenesis system for Drosophila using germ-line-specific PhiC31 integrases. Proc. Natl. Acad. Sci. USA 2007, 104, 3312–3317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Fields, S.; Song, O.K. A novel genetic system to detect protein-protein interactions. Nature 1989, 340, 245–246. [Google Scholar] [CrossRef] [PubMed]
  45. Gyuris, J.; Golemis, E.; Chertkov, H.; Brent, R. Cdi1, a human G1 and S phase protein phosphatase that associates with cdk2. Cell 1993, 75, 791–803. [Google Scholar] [CrossRef]
  46. Brand, A.H.; Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993, 118, 401–415. [Google Scholar] [PubMed]
  47. Protzer, C.E.; Wech, I.; Nagel, A.C. Hairless induces cell death by downregulation of EGFR signalling activity. J. Cell Sci. 2008, 121, 3167–3176. [Google Scholar] [CrossRef] [Green Version]
  48. Lecuit, T.; Brook, W.J.; Ng, M.; Calleja, M.; Sun, H.; Cohen, S.M. Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing. Nature 1996, 381, 387–393. [Google Scholar] [CrossRef]
  49. Auer, J.S.; Nagel, A.C.; Schulz, A.; Wahl, V.; Preiss, A. MAPK-dependent phosphorylation modulates the activity of Suppressor of Hairless in Drosophila. Cell. Signal. 2015, 27, 115–124. [Google Scholar] [CrossRef]
  50. Kim, J.; Sebring, A.; Esch, J.J.; Kraus, M.E.; Vorwerk, K.; Magee, J.; Carroll, S.B. Integration of positional signals and regulation of wing formation and identity by Drosophila vestigial gene. Nature 1996, 382, 133–138. [Google Scholar] [CrossRef]
  51. Brou, C.; Logeat, F.; Lecourtois, M.; Vandekerckhove, J.; Kourilsky, P.; Schweisguth, F.; Israël, A. Inhibition of the DNA-binding activity of Drosophila Suppressor of Hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila Hairless. Genes Dev. 1994, 8, 2491–2503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Morel, V.; Lecourtois, M.; Massiani, O.; Maier, D.; Preiss, A.; Schweisguth, F. Transcriptional repression by Suppressor of Hairless involves the binding of a Hairless-dCtBP complex in Drosophila. Curr. Biol. 2001, 11, 789–792. [Google Scholar] [CrossRef] [Green Version]
  53. Yuan, Z.; Praxenthaler, H.; Tabaja, N.; Torella, R.; Preiss, A.; Maier, D.; Kovall, R.A. Structure and function of the Su(H)-Hairless repressor complex, the major antagonist of Notch signalling in Drosophila melanogaster. PLoS Biol. 2016, 14, e1002509. [Google Scholar] [CrossRef] [PubMed]
  54. Nagel, A.C.; Preiss, A. Fine tuning of Notch signaling by differential co-repressor recruitment during eye development of Drosophila. Hereditas 2011, 148, 77–84. [Google Scholar] [CrossRef]
  55. Maier, D.; Stumm, G.; Kuhn, K.; Preiss, A. Hairless, a Drosophila gene involved in neural development, encodes a novel, serine rich protein. Mech. Dev. 1992, 38, 143–156. [Google Scholar] [CrossRef]
  56. Go, M.J.; Eastman, D.S.; Artavanis-Tsakonas, S. Cell proliferation control by Notch signaling in Drosophila development. Development 1998, 125, 2031–2040. [Google Scholar]
  57. Furriols, M.; Bray, S. Dissecting the mechanisms of Suppressor of Hairless function. Dev. Biol. 2000, 227, 520–532. [Google Scholar] [CrossRef] [Green Version]
  58. Goodfellow, H.; Krejcí, A.; Moshkin, Y.; Verrijzer, C.P.; Karch, F.; Bray, S.J. Gene-specific targeting of the histone chaperone Asf1 to mediate silencing. Dev. Cell. 2007, 13, 593–600. [Google Scholar] [CrossRef] [Green Version]
  59. Moshkin, Y.M.; Kan, T.W.; Goodfellow, H.; Bezstarosti, K.; Maeda, R.K.; Pilyugin, M.; Karch, F.; Bray, S.J.; Demmers, J.A.; Verrijzer, C.P. Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing. Mol. Cell. 2009, 35, 782–793. [Google Scholar] [CrossRef]
  60. Crozatier, M.; Glise, B.; Vincent, A. Patterns in evolution: Veins of the Drosophila wing. Trends Genet. 2004, 20, 498–505. [Google Scholar] [CrossRef]
  61. de Celis, J.F. Expression and function of decapentaplegic and thick veins during the differentiation of the veins in the Drosophila wing. Development 1997, 124, 1007–1018. [Google Scholar] [PubMed]
  62. Sotillos, S.; de Celis, J.F. Regulation of decapentaplegic expression during Drosophila wing veins pupal development. Mech. Dev. 2005, 123, 241–251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. de Celis, J.F.; Ruiz-Gómez, M. groucho and hedgehog regulate engrailed expression in the anterior compartment of the Drosophila wing. Development 1995, 121, 3467–3476. [Google Scholar] [PubMed]
  64. Nagel, A.C.; Preiss, A. Mutation of potential MAPK phosphorylation sites in the Notch antagonist Hairless. Hereditas 2014, 151, 102–108. [Google Scholar] [CrossRef] [PubMed]
  65. Kim, S.M.; Kim, M.Y.; Ann, E.J.; Mo, J.S.; Yoon, J.H.; Park, H.S. Presenilin-2 regulates the degradation of RBP-Jk protein through p38 mitogen-activated protein kinase. J. Cell Sci. 2012, 125, 1296–1308. [Google Scholar] [CrossRef] [Green Version]
  66. Schertel, C.; Albarca, M.; Rockel-Bauer, C.; Kelley, N.W.; Bischof, J.; Hens, K.; van Nimwegen, E.; Basler, K.; Deplancke, B. A large-scale, in vivo transcription factor screen defines bivalent chromatin as a key property of regulatory factors mediating Drosophila wing development. Genome Res. 2015, 25, 514–523. [Google Scholar] [CrossRef] [Green Version]
  67. Roch, F.; Jiménez, G.; Casanova, J. EGFR signalling inhibits Capicua-dependent repression during specification of Drosophila wing veins. Development 2002, 129, 993–1002. [Google Scholar]
  68. Terriente-Félix, A.; Molnar, C.; Gómez-Skarmeta, J.L.; de Celis, J.F. A conserved function of the chromatin ATPase Kismet in the regulation of hedgehog expression. Dev. Biol. 2011, 350, 382–392. [Google Scholar] [CrossRef]
  69. Gómez, A.R.; López-Varea, A.; Molnar, C.; de la Calle-Mustienes, E.; Ruiz-Gómez, M.; Gómez-Skarmeta, J.L.; de Celis, J.F. Conserved cross-interactions in Drosophila and Xenopus between Ras/MAPK signaling and the Dual-Specificity Phosphatase MKP3. Dev. Dyn. 2005, 232, 695–708. [Google Scholar] [CrossRef]
  70. Reich, A.; Sapir, A.; Shilo, B. Sprouty is a general inhibitor of Receptor Tyrosine Kinase signaling. Development 1999, 126, 4139–4147. [Google Scholar]
  71. Kramer, S.; Okabe, M.; Hacohen, N.; Krasnow, M.A.; Hiromi, Y. Sprouty, a common antagonist of FGF and EGF pathways in Drosophila. Development 1999, 126, 2515–2525. [Google Scholar] [PubMed]
  72. Jiménez, G.; Guichet, A.; Ephrussi, A.; Casanova, J. Relief of gene repression by Torso RTK signaling: Role of Capicua in Drosophila terminal and dorsoventral patterning. Genes Dev. 2000, 14, 224–231. [Google Scholar] [PubMed]
  73. Hasson, P.; Müller, B.; Basler, K.; Paroush, Z. Brinker requires two corepressors for maximal and versatile repression in Dpp signalling. EMBO J. 2001, 20, 5725–5736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Zhang, H.; Levine, M.; Ashe, H.L. Brinker is a sequence-specific transcriptional repressor in the Drosophila embryo. Genes Dev. 2001, 15, 261–266. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Cook, O.; Biehs, B.; Bier, E. brinker and optomotor-blind act coordinately to initiate development of the L5 wing vein primordium in Drosophila. Development 2004, 131, 2113–2124. [Google Scholar] [CrossRef] [Green Version]
  76. Winter, S.E.; Campbell, G. Repression of Dpp targets in the Drosophila wing by Brinker. Development 2004, 131, 6071–6081. [Google Scholar] [CrossRef] [Green Version]
  77. Funakoshi, Y.; Minami, M.; Tabata, T. MTV shapes the activity gradient of the Dpp morphogen through regulation of thickveins. Development 2001, 128, 67–74. [Google Scholar]
  78. Nibu, Y.; Zhang, H.; Bajor, E.; Barolo, S.; Small, S.; Levine, M. dCtBP mediates transcriptional repression by Knirps, Krüppel and Snail in the Drosophila embryo. EMBO J. 1998, 17, 7009–7020. [Google Scholar] [CrossRef] [Green Version]
  79. Paynkaulam, S.; Arnosti, D.N. Groucho corepressor functions as a cofactor for the Knirps short-range transcriptional repressor. Proc. Natl. Acad. Sci. USA 2009, 106, 17314–17319. [Google Scholar] [CrossRef] [Green Version]
  80. Delidakis, C.; Monastirioti, M.; Magadi, S.S. E(spl): Genetic, developmental, and evolutionary aspects of a group of invertebrate HES proteins with close ties to Notch signaling. Curr. Top. Dev. Biol. 2014, 110, 217–262. [Google Scholar] [CrossRef]
  81. Horvath, M.; Mihajlovic, Z.; Slaninova, V.; Perez-Gomez, R.; Moshkin, Y.; Krejci, A. The silent information regulator 1 (Sirt1) is a positive regulator of the Notch pathway in Drosophila. Biochem. J. 2016, 473, 4129–4143. [Google Scholar] [CrossRef] [PubMed]
  82. Zhang, X.; Miao, C.; Nan, Z.; Lyu, J.; Xi, Y.; Yang, X.; Ge, W. A positive role of Sin3A in regulating Notch signaling during Drosophila wing development. Cell. Signal. 2019, 53, 184–189. [Google Scholar] [CrossRef] [PubMed]
  83. Kingston, R.E.; Tamkun, J.W. Transcriptional regulation by Trithorax-group proteins. Cold Spring Harbor Perspect. Biol. 2014, 6, a019349. [Google Scholar] [CrossRef] [PubMed]
  84. Gervais, L.; van den Beek, M.; Josserand, M.; Sallé, J.; Stefanutti, M.; Perdigoto, C.N.; Skorski, P.; Mazouni, K.; Marshall, O.J.; Brand, A.H.; et al. Stem cell proliferation is kept in check by the chromatin regulators Kismet/CHD7/CHD8 and Trr/MLL3/4. Dev. Cell 2019, 49, 556–573. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Mulligan, P.; Yang, F.; Di Stefano, L.; Ji, J.Y.; Ouyang, J.; Nishikawa, J.L.; Toiber, D.; Kulkarni, M.; Wang, Q.; Najafi-Shoushtari, S.H.; et al. A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development. Mol. Cell 2011, 42, 689–699. [Google Scholar] [CrossRef] [Green Version]
  86. Curtis, B.J.; Zraly, C.B.; Marenda, D.R.; Dingwall, A.K. Histone lysine demethylases function as co-repressors of SWI/SNF remodeling activities during Drosophila wing development. Dev. Biol. 2011, 350, 534–547. [Google Scholar] [CrossRef] [Green Version]
  87. Curtis, B.J.; Zraly, C.B.; Dingwall, A.K. Drosophila Lsd1-CoREST demethylase complex regulates DPP/TGFß signaling during wing development. Genesis 2013, 51, 16–31. [Google Scholar] [CrossRef]
  88. Shi, Y.; Sawada, J.; Sui, G.; Affar, B.; Whetstine, J.R.; Lan, F.; Ogawa, H.; Luke, M.P.; Nakatani, Y.; Shi, Y. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003, 422, 735–738. [Google Scholar] [CrossRef]
Figure 1. Hairless mutants affecting Su(H) and co-repressor binding. (a) Scheme of the H protein with the Su(H)-binding domain (SBD, cyan), the Gro-binding domain (GBD, blue), and the CtBP-binding domain (CBD, purple) indicated. Numbering is according to [55]. The C2 deletion is shown in grey. The NT-box is part of the SBD and contains amino acids in direct contact with Su(H) (bold) [53]. Residues involved in the binding of Gro or CtBP are likewise shown in bold [9]. Amino acid replacements are indicated in red: HLD impairs the interaction with Su(H), H*G prevents binding to Gro, and H*C to CtBP [9,40]. H* mutations used in this study are depicted underneath. (b) Structure of the H-Su(H) repressor complex (PDB ID: 5E24) [53]. The picture focuses on the C-terminal domain (CTD) of Su(H) in yellow with amino acids important for H binding shown in pink (L343, L445, L514). The domain in H interacting with Su(H) (H NT, aa 232–269) is shown in cyan; L235 is labelled. (c) Pairwise protein–protein interactions assayed by yeast two-hybrid: H wild type or H* mutant constructs in pEG vector served as bait, whereas Su(H) in pJG vector, and either Gro or CtBP in VP16 vector served as prey. Blue colonies reveal pairwise protein interactions, whereas white colonies show respective lack of interaction. Empty vectors served as controls. (d) Control wing of a female fly: longitudinal veins L1-L5 and anterior and posterior cross veins (acv, pcv) are labelled (QE-Gal4::UAS-GFP). (e) Wing of a female fly overexpressing HC2 in the wing blade (QE-Gal4::UAS-H-C2). Note plexus of ectopic veins along the L2 and L5 veins (arrowheads).
Figure 1. Hairless mutants affecting Su(H) and co-repressor binding. (a) Scheme of the H protein with the Su(H)-binding domain (SBD, cyan), the Gro-binding domain (GBD, blue), and the CtBP-binding domain (CBD, purple) indicated. Numbering is according to [55]. The C2 deletion is shown in grey. The NT-box is part of the SBD and contains amino acids in direct contact with Su(H) (bold) [53]. Residues involved in the binding of Gro or CtBP are likewise shown in bold [9]. Amino acid replacements are indicated in red: HLD impairs the interaction with Su(H), H*G prevents binding to Gro, and H*C to CtBP [9,40]. H* mutations used in this study are depicted underneath. (b) Structure of the H-Su(H) repressor complex (PDB ID: 5E24) [53]. The picture focuses on the C-terminal domain (CTD) of Su(H) in yellow with amino acids important for H binding shown in pink (L343, L445, L514). The domain in H interacting with Su(H) (H NT, aa 232–269) is shown in cyan; L235 is labelled. (c) Pairwise protein–protein interactions assayed by yeast two-hybrid: H wild type or H* mutant constructs in pEG vector served as bait, whereas Su(H) in pJG vector, and either Gro or CtBP in VP16 vector served as prey. Blue colonies reveal pairwise protein interactions, whereas white colonies show respective lack of interaction. Empty vectors served as controls. (d) Control wing of a female fly: longitudinal veins L1-L5 and anterior and posterior cross veins (acv, pcv) are labelled (QE-Gal4::UAS-GFP). (e) Wing of a female fly overexpressing HC2 in the wing blade (QE-Gal4::UAS-H-C2). Note plexus of ectopic veins along the L2 and L5 veins (arrowheads).
Genes 11 01141 g001
Figure 2. Overexpression of H protein variants in the central wing anlagen using omb-Gal4. (ad’) The transgenes, as indicated, were overexpressed in the central part of the wing anlagen using omb-Gal4 at 20 °C. Female wings are shown. (a) UAS-GFP served as control. (b) Wing incisions (asterisk), proliferation defects, and vein thickening (arrowhead) were typical consequences of an inhibition of Notch activity resulting from overexpression of wild type H protein. (c,d) Overexpression of either HdNT or HLD mutants did not affect the wing margin. Note, however, ectopic wing vein formation (arrowheads mark examples) and slightly reduced wing size. (a’d’) Combined overexpression of Su(H) and H variants. (a’) Whereas the overexpression Su(H) within the wing anlagen resulted in crumbled wings, a combination with wild type H was lethal as a consequence of excessive repressor complex formation (b’) [9,40,52,53]. In combination with either (c’) HdNT or (d’) HLD, however, the wings resembled those of the sole Su(H) overexpression.
Figure 2. Overexpression of H protein variants in the central wing anlagen using omb-Gal4. (ad’) The transgenes, as indicated, were overexpressed in the central part of the wing anlagen using omb-Gal4 at 20 °C. Female wings are shown. (a) UAS-GFP served as control. (b) Wing incisions (asterisk), proliferation defects, and vein thickening (arrowhead) were typical consequences of an inhibition of Notch activity resulting from overexpression of wild type H protein. (c,d) Overexpression of either HdNT or HLD mutants did not affect the wing margin. Note, however, ectopic wing vein formation (arrowheads mark examples) and slightly reduced wing size. (a’d’) Combined overexpression of Su(H) and H variants. (a’) Whereas the overexpression Su(H) within the wing anlagen resulted in crumbled wings, a combination with wild type H was lethal as a consequence of excessive repressor complex formation (b’) [9,40,52,53]. In combination with either (c’) HdNT or (d’) HLD, however, the wings resembled those of the sole Su(H) overexpression.
Genes 11 01141 g002
Figure 3. Overexpression of H protein variants in the presumptive wing tissue using QE-Gal4. (ad’) UAS-H* transgenes, as indicated, were overexpressed in the presumptive wing tissue using QE-Gal4 at 18 °C. (a) UAS-GFP served as control; longitudinal veins are numbered. (b) Overexpression of wild type H protein affected wing size and tissue adhesion (asterisk). The most prominent phenotype, however, was a thickening of veins and formation of ectopic veinlets (arrowheads point to examples). (c,d) The latter was also observed upon the overexpression of HdNT (c) or HLD (d) variants compromised in Su(H) binding (arrowheads point to examples). (a’d’) UAS-Su(H) plus the respective UAS-H* transgenes were overexpressed in combination in the developing wing field with QE-Gal4. (a’) Su(H) overexpression alone caused a loss of distal parts of longitudinal veins (arrow). (b’) A combined overexpression of UAS-Su(H) with UAS-H resulted in a transformation of intervein to vein tissue, as well as the emergence of ectopic bristle organs (open arrow, see enlargement). Combination of Su(H) with either HdNT (c’) or HLD (d’), however, gave a mixed phenotype with erased distal wing veins (arrow) plus ectopic veinlets (arrowheads), indicating lack of repressor complex formation. Female wings are shown.
Figure 3. Overexpression of H protein variants in the presumptive wing tissue using QE-Gal4. (ad’) UAS-H* transgenes, as indicated, were overexpressed in the presumptive wing tissue using QE-Gal4 at 18 °C. (a) UAS-GFP served as control; longitudinal veins are numbered. (b) Overexpression of wild type H protein affected wing size and tissue adhesion (asterisk). The most prominent phenotype, however, was a thickening of veins and formation of ectopic veinlets (arrowheads point to examples). (c,d) The latter was also observed upon the overexpression of HdNT (c) or HLD (d) variants compromised in Su(H) binding (arrowheads point to examples). (a’d’) UAS-Su(H) plus the respective UAS-H* transgenes were overexpressed in combination in the developing wing field with QE-Gal4. (a’) Su(H) overexpression alone caused a loss of distal parts of longitudinal veins (arrow). (b’) A combined overexpression of UAS-Su(H) with UAS-H resulted in a transformation of intervein to vein tissue, as well as the emergence of ectopic bristle organs (open arrow, see enlargement). Combination of Su(H) with either HdNT (c’) or HLD (d’), however, gave a mixed phenotype with erased distal wing veins (arrow) plus ectopic veinlets (arrowheads), indicating lack of repressor complex formation. Female wings are shown.
Genes 11 01141 g003
Figure 4. Loss of co-repressor binding inhibited ectopic vein formation by H protein overexpressed in the central wing anlagen. (ad’) UAS-H* transgenes, as indicated, were overexpressed in the central part of the wing anlagen using omb-Gal4 at 25 °C. Note enhancement of phenotypes at the higher temperature (compare with Figure 2). (a) UAS-GFP served as control. (b) Wing incisions (asterisk) are very deep when H is induced. Overexpression of either HdNT (c) or HLD (d) isoforms, however, induced a lattice of veinlets (arrowheads point to examples). The margin was unaffected, however. (b’d’) Overexpression of the respective H* protein isoforms lacking Gro and CtBP co-repressor binding in addition to compromised Su(H) binding (*GC; see Figure 1). (b’) Loss of co-repressors impeded H repressor activity. Accordingly, mild wing incisions were seen when UAS-H*GC was overexpressed. In contrast, overexpression of either HdNT*GC (c) or HLD*GC (d) variants affecting both Su(H) and co-repressor binding neither affected wing margin nor vein development. Female wings are shown.
Figure 4. Loss of co-repressor binding inhibited ectopic vein formation by H protein overexpressed in the central wing anlagen. (ad’) UAS-H* transgenes, as indicated, were overexpressed in the central part of the wing anlagen using omb-Gal4 at 25 °C. Note enhancement of phenotypes at the higher temperature (compare with Figure 2). (a) UAS-GFP served as control. (b) Wing incisions (asterisk) are very deep when H is induced. Overexpression of either HdNT (c) or HLD (d) isoforms, however, induced a lattice of veinlets (arrowheads point to examples). The margin was unaffected, however. (b’d’) Overexpression of the respective H* protein isoforms lacking Gro and CtBP co-repressor binding in addition to compromised Su(H) binding (*GC; see Figure 1). (b’) Loss of co-repressors impeded H repressor activity. Accordingly, mild wing incisions were seen when UAS-H*GC was overexpressed. In contrast, overexpression of either HdNT*GC (c) or HLD*GC (d) variants affecting both Su(H) and co-repressor binding neither affected wing margin nor vein development. Female wings are shown.
Genes 11 01141 g004
Figure 5. Overexpression of H* protein lacking Su(H) and co-repressor binding ability in the developing wing blade. (ad’) UAS-H* transgenes, as indicated, were induced at 25 °C with QE-Gal4 in presumptive wing tissue. (a) UAS-GFP served as control. (b) Whereas wild type H induced wing blisters (asterisk) and thickened veins (arrowheads), HdNT*GC (c) and HLD*GC (d) isoforms induced ectopic veinlets (arrowheads point to examples). (b’d’) Overexpression of the respective H* protein isoforms that in addition lack Gro and CtBP co-repressor binding (*GC; see Figure 1a). Overall, the wings resembled the control. However, minute veinlets may appear in the developing wing blade. Examples are shown for (c’) HdNT*GC and (d’) HLD*GC (arrows). Female wings are shown.
Figure 5. Overexpression of H* protein lacking Su(H) and co-repressor binding ability in the developing wing blade. (ad’) UAS-H* transgenes, as indicated, were induced at 25 °C with QE-Gal4 in presumptive wing tissue. (a) UAS-GFP served as control. (b) Whereas wild type H induced wing blisters (asterisk) and thickened veins (arrowheads), HdNT*GC (c) and HLD*GC (d) isoforms induced ectopic veinlets (arrowheads point to examples). (b’d’) Overexpression of the respective H* protein isoforms that in addition lack Gro and CtBP co-repressor binding (*GC; see Figure 1a). Overall, the wings resembled the control. However, minute veinlets may appear in the developing wing blade. Examples are shown for (c’) HdNT*GC and (d’) HLD*GC (arrows). Female wings are shown.
Genes 11 01141 g005
Figure 6. Model explaining the ectopic veinlet phenotype. (a) General co-repressors Gro and CtBP are shared by numerous regulators acting in different signaling pathways, including Brinker (Brk), Capicua (Cic), and E(spl) and Hairy (HES)-type transcription factors. Moreover, Hairless recruits both co-repressors for Su(H)-H repressor complex formation. (b) Overexpression of H* variants defective for Su(H)-binding does not influence Notch target gene expression any longer. H* variants, however, may compete with other transcription factors for the binding to co-repressors, thereby limiting their availability. As a consequence, H* overexpression may intercept with signaling pathways involved in vein formation that are specifically sensitive towards a mitigation of co-repressor availability.
Figure 6. Model explaining the ectopic veinlet phenotype. (a) General co-repressors Gro and CtBP are shared by numerous regulators acting in different signaling pathways, including Brinker (Brk), Capicua (Cic), and E(spl) and Hairy (HES)-type transcription factors. Moreover, Hairless recruits both co-repressors for Su(H)-H repressor complex formation. (b) Overexpression of H* variants defective for Su(H)-binding does not influence Notch target gene expression any longer. H* variants, however, may compete with other transcription factors for the binding to co-repressors, thereby limiting their availability. As a consequence, H* overexpression may intercept with signaling pathways involved in vein formation that are specifically sensitive towards a mitigation of co-repressor availability.
Genes 11 01141 g006

Share and Cite

MDPI and ACS Style

Nagel, A.C.; Maier, D.; Scharpf, J.; Ketelhut, M.; Preiss, A. Limited Availability of General Co-Repressors Uncovered in an Overexpression Context during Wing Venation in Drosophila melanogaster. Genes 2020, 11, 1141. https://0-doi-org.brum.beds.ac.uk/10.3390/genes11101141

AMA Style

Nagel AC, Maier D, Scharpf J, Ketelhut M, Preiss A. Limited Availability of General Co-Repressors Uncovered in an Overexpression Context during Wing Venation in Drosophila melanogaster. Genes. 2020; 11(10):1141. https://0-doi-org.brum.beds.ac.uk/10.3390/genes11101141

Chicago/Turabian Style

Nagel, Anja C., Dieter Maier, Janika Scharpf, Manuela Ketelhut, and Anette Preiss. 2020. "Limited Availability of General Co-Repressors Uncovered in an Overexpression Context during Wing Venation in Drosophila melanogaster" Genes 11, no. 10: 1141. https://0-doi-org.brum.beds.ac.uk/10.3390/genes11101141

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop